Company intelligence / Profile preview

Temmler

Marburg, Hesse, Germanyen.wikipedia.org ↗

Ownership: Private
Development stage: Other

Overview

Temmler was a leading German pharmaceutical manufacturer and CDMO specializing in solid oral dosage forms with expertise in modified-release formulations. It historically developed products for CNS disorders and rare diseases but shifted to contract manufacturing. In recent years its production sites became part of Aenova Group while its neurology product portfolio was acquired by Lupin Limited.

Therapeutic areas: PulmonologyGastroenterologyNeurology
Modalities: Small moleculeSolid dosage forms (tablets, capsules)Semi-solid and liquid dosage formsModified release formulations
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Temmler.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Temmler.

Explore the full profile